Literature DB >> 29980791

ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer.

Xiao Guo1,2, Yin Zhang3, Anand Mayakonda4, Vikas Madan4, Ling-Wen Ding4, Le-Hang Lin3, Saadiya Zia5, Sigal Gery5, Jeffrey W Tyner6, Wu Zhou7, Dong Yin3, De-Chen Lin8, H Phillip Koeffler5,4,9.   

Abstract

As one of the primary members of SWI/SNF chromatin remodeling complexes, ARID1A contains frequent loss-of-function mutations in many types of cancers. However, the molecular mechanisms underlying ARID1A deficiency in cancer biology remain to be investigated. Using breast cancer as a model, we report that silencing ARID1A significantly increased cellular proliferation and migration. Mechanistically, primarily functioning as a transcriptional repressor, loss of ARID1A profoundly alters histone modifications and the transcriptome. Notably, ARID1A inhibited the expression of a long non-coding RNA, UCA1, by regulating chromatin access of the transcription factor CEBPα. Restoration experiments showed that UCA1 mediates the functions of ARID1A that induces loss of cellular proliferation and migration. Together, our findings characterize ARID1A as a key tumor-suppressor gene in breast cancer through cooperation with CEBPα, and loss-of-function mutations of ARID1A activates UCA1.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29980791     DOI: 10.1038/s41388-018-0371-4

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

1.  Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.

Authors:  Xianyu Zhang; Youxue Zhang; Yanmei Yang; Ming Niu; Shanshan Sun; Hongfei Ji; Yuyan Ma; Guodong Yao; Yongdong Jiang; Ming Shan; Guoqiang Zhang; Da Pang
Journal:  Cancer Epidemiol       Date:  2011-09-01       Impact factor: 2.984

Review 2.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

3.  Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.

Authors:  Wenbin Xiao; Amad Awadallah; Wei Xin
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

4.  ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.

Authors:  Jianfeng Shen; Yang Peng; Leizhen Wei; Wei Zhang; Lin Yang; Li Lan; Prabodh Kapoor; Zhenlin Ju; Qianxing Mo; Ie-Ming Shih; Ivan P Uray; Xiangwei Wu; Powel H Brown; Xuetong Shen; Gordon B Mills; Guang Peng
Journal:  Cancer Discov       Date:  2015-06-11       Impact factor: 39.397

5.  Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas.

Authors:  Kimberly C Wiegand; Anna F Lee; Osama M Al-Agha; Christine Chow; Steve E Kalloger; David W Scott; Christian Steidl; Sam M Wiseman; Randy D Gascoyne; Blake Gilks; David G Huntsman
Journal:  J Pathol       Date:  2011-05-18       Impact factor: 7.996

6.  Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.

Authors:  Siân Jones; Tian-Li Wang; Ie-Ming Shih; Tsui-Lien Mao; Kentaro Nakayama; Richard Roden; Ruth Glas; Dennis Slamon; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Nickolas Papadopoulos
Journal:  Science       Date:  2010-09-08       Impact factor: 47.728

7.  Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions.

Authors:  Bin Guan; Min Gao; Chen-Hsuan Wu; Tian-Li Wang; Ie-Ming Shih
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

Review 8.  ARID1A gene mutation in ovarian and endometrial cancers (Review).

Authors:  Takashi Takeda; Kouji Banno; Ryuichiro Okawa; Megumi Yanokura; Moito Iijima; Haruko Irie-Kunitomi; Kanako Nakamura; Miho Iida; Masataka Adachi; Kiyoko Umene; Yuya Nogami; Kenta Masuda; Yusuke Kobayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  Oncol Rep       Date:  2015-11-16       Impact factor: 3.906

9.  Patulin induces pro-survival functions via autophagy inhibition and p62 accumulation.

Authors:  X Guo; Y Dong; S Yin; C Zhao; Y Huo; L Fan; H Hu
Journal:  Cell Death Dis       Date:  2013-10-03       Impact factor: 8.469

10.  Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas.

Authors:  De-Chen Lin; Huy Q Dinh; Jian-Jun Xie; Anand Mayakonda; Tiago Chedraoui Silva; Yan-Yi Jiang; Ling-Wen Ding; Jian-Zhong He; Xiu-E Xu; Jia-Jie Hao; Ming-Rong Wang; Chunquan Li; Li-Yan Xu; En-Min Li; Benjamin P Berman; H Phillip Koeffler
Journal:  Gut       Date:  2017-08-31       Impact factor: 31.793

View more
  9 in total

1.  TGF-β1/Smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.

Authors:  Zhangshuo Yang; Hao Zhang; Maohui Yin; Zhixiang Cheng; Ping Jiang; Maohui Feng; Zhisu Liu; Bo Liao
Journal:  J Mol Med (Berl)       Date:  2022-08-24       Impact factor: 5.606

Review 2.  ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.

Authors:  Olena Odnokoz; Cindy Wavelet-Vermuse; Shelby L Hophan; Serdar Bulun; Yong Wan
Journal:  Epigenomics       Date:  2021-04-23       Impact factor: 4.778

Review 3.  Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia.

Authors:  Alexander A Wurm; Cristina Pina
Journal:  Front Oncol       Date:  2019-09-11       Impact factor: 6.244

4.  Expression and prognostic values of ARID family members in breast cancer.

Authors:  Jinfeng Zhang; Siyu Hou; Zilong You; Guozheng Li; Shouping Xu; Xianyong Li; Xianyu Zhang; Bo Lei; Da Pang
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

5.  Acute depletion of the ARID1A subunit of SWI/SNF complexes reveals distinct pathways for activation and repression of transcription.

Authors:  Seraina Blümli; Nicola Wiechens; Meng-Ying Wu; Vijender Singh; Marek Gierlinski; Gabriele Schweikert; Nick Gilbert; Catherine Naughton; Ramasubramanian Sundaramoorthy; Joby Varghese; Robert Gourlay; Renata Soares; David Clark; Tom Owen-Hughes
Journal:  Cell Rep       Date:  2021-11-02       Impact factor: 9.423

6.  Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression.

Authors:  Xue Yang; Yunqing Yang; Xueke Qian; Xiaodong Xu; Pengwei Lv
Journal:  Biomed J       Date:  2021-05-29       Impact factor: 7.892

7.  ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness.

Authors:  Qingyu Luo; Xiaowei Wu; Wan Chang; Pengfei Zhao; Yabing Nan; Xiaolin Zhu; Jonathan P Katz; Dan Su; Zhihua Liu
Journal:  Cell Death Differ       Date:  2019-12-12       Impact factor: 15.828

Review 8.  Epigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer.

Authors:  Bernadette Neve; Nicolas Jonckheere; Audrey Vincent; Isabelle Van Seuningen
Journal:  Cancers (Basel)       Date:  2018-11-14       Impact factor: 6.639

9.  Proline-Rich Acidic Protein 1 (PRAP1) is a Target of ARID1A and PGR in the Murine Uterus.

Authors:  Tae Hoon Kim; Jae-Wook Jeong
Journal:  Dev Reprod       Date:  2019-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.